Jump to content
RemedySpot.com

3 Early View articles are now available on Wiley Online Library

Rate this topic


Guest guest

Recommended Posts

Liver InternationalLiver International © Wiley & Sons A/S

Early View (Articles online in advance of print)

Clinical Studies

Adherence to treatment and quality of life during hepatitis C therapy: a

prospective, real-life, observational study

Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel

Rotily, Marina Varastet, Jean-Philippe Lang, Pascal Melin and Patrice Cacoub,

for the CheObs Study Group

Article first published online: 15 FEB 2011 | DOI:

10.1111/j.1478-3231.2011.02461.x

Corrigendum

CORRIGENDUM

Article first published online: 17 FEB 2011 | DOI:

10.1111/j.1478-3231.2011.02492.x

This article corrects:

Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and

ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of

life analysis

Vol. 31, Issue 3, 401–411, Article first published online: 11 JAN 2011

These Early View articles are now available on Wiley Online Library

Basic Studies

A glycyrrhizin-containing preparation reduces hepatic steatosis induced by

hepatitis C virus protein and iron in mice

Masaaki Korenaga, Isao Hidaka, Sohji Nishina, Aya Sakai, Akane Shinozaki,

Toshikazu Gondo, Takakazu Furutani, Hiroo Kawano, Isao Sakaida and Keisuke Hino

Article first published online: 15 FEB 2011 | DOI:

10.1111/j.1478-3231.2011.02469.x

Link to comment
Share on other sites

Liver InternationalLiver International © Wiley & Sons A/S

Early View (Articles online in advance of print)

Clinical Studies

Adherence to treatment and quality of life during hepatitis C therapy: a

prospective, real-life, observational study

Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel

Rotily, Marina Varastet, Jean-Philippe Lang, Pascal Melin and Patrice Cacoub,

for the CheObs Study Group

Article first published online: 15 FEB 2011 | DOI:

10.1111/j.1478-3231.2011.02461.x

Corrigendum

CORRIGENDUM

Article first published online: 17 FEB 2011 | DOI:

10.1111/j.1478-3231.2011.02492.x

This article corrects:

Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and

ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of

life analysis

Vol. 31, Issue 3, 401–411, Article first published online: 11 JAN 2011

These Early View articles are now available on Wiley Online Library

Basic Studies

A glycyrrhizin-containing preparation reduces hepatic steatosis induced by

hepatitis C virus protein and iron in mice

Masaaki Korenaga, Isao Hidaka, Sohji Nishina, Aya Sakai, Akane Shinozaki,

Toshikazu Gondo, Takakazu Furutani, Hiroo Kawano, Isao Sakaida and Keisuke Hino

Article first published online: 15 FEB 2011 | DOI:

10.1111/j.1478-3231.2011.02469.x

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...